Medication Growth Following Diagnosis of Intellectual and Developmental Disabilities at Varying Ages Throughout Childhood
Robert B Christian, Izabela E Annis, Neal A deJong, Scott A Davis, Phillip M Hughes, Kathleen C Thomas · 2026
Read Medication Growth Following Diagnosis of Intellectual and Developmental Disabilities at Varying Ages Throughout Childhood by Robert B Christian, Izabela E Annis, Neal A deJong, Scott A Davis, Phillip M Hughes, Kathleen C Thomas (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13481131.txt.
Description
Robert Christian and co-authors track in 2026 how use of psychiatric medicines grows after children are diagnosed with intellectual and developmental disabilities. Long term prescribing patterns by age at diagnosis were poorly known. Using insurance claims from the southeast United States for 2011 to 2021, the study followed 938 children aged two to seventeen who were newly diagnosed.
Within three years, about forty percent had started such a medicine and about nine percent used two or more classes for a sustained period. Use grew each year for children diagnosed before age twelve, with the youngest group showing the largest rise. Teens diagnosed later started higher but grew little. Readers see why age at diagnosis shapes later drug burden.
Catalog record
| CREATOR | Robert B Christian, Izabela E Annis, Neal A deJong, Scott A Davis, Phillip M Hughes, Kathleen C Thomas |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 34 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |